SCHEMBL5089564

SCHEMBL5089564

CCCCC#CCCC#Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.47
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 3/20 0.47
THPO P40225 1/20 0.47
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
MMP2 P08253 1/20 0.45
MMP12 P39900 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
TNK2 Q07912 1/20 0.44
HTR2A P28223 1/20 0.44
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
APP P05067 1/20 0.42
MAPT P10636 4/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL614578 0.96 CYP1A2 (0.50) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL31144511 0.94 BLM (0.52) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5314931 0.90 FFAR1 (0.55) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4073903 0.88 FFAR1 (0.58) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL2350387 0.88 FFAR1 (0.58) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL2027461 0.88 FFAR1 (0.58) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL4071200 0.88 FFAR1 (0.58) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9015870 0.88 FFAR1 (0.58) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7139040 0.88 FFAR1 (0.58) NPSR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5886588 0.85 FFAR1 (0.53) FFAR1FFAR4MMP2MMP12TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B NPSR1 1932/4885CYP1A2 436/4885CYP3A4 542/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A NPSR1 1557/4885CYP1A2 777/4885CYP3A4 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.